
Chemical and Pharmaceutical Bulletin p. 1428 - 1431 (1998)
Update date:2022-07-30
Topics: Synthesis 5-Fluorouracil
Hanif, Raja Muhammad
Qineng, Ping
Fenzhu, Muo
The tetrahydrogeraniol (THG) derivative, ethyl-(3,7-dimethyl octyl thio) acetate (EDOTA) was prepared by reacting tetrahydrogeranyl bromide (obtained by reaction of 40% hydrobromic acid and concentrated sulfuric acid) with ethyl 2-mercaptoacetate, while 3,7-dimethyl octyl propionate (DOP) was synthesized by a common esterification reaction by reacting THG with propionic acid in the presence of cyclohexane and concentrated sulfuric acid. The penetration-enhancing effect of the new enhancers were compared with THG and Azone in vitro using excised rat skin in modified Franz-type diffusion cells. 5-Fluorouracil (5-FU), a hydrophilic drug with poor skin permeability was used as a model permeant. Skin samples were pretreated with pure liquid enhancers for 12 h. 5-FU flux through the control and enhancer-treated skin increased linearly with its concentration in the receptor compartment. EDOTA and DOP interacted with the skin rapidly (<2 h), and the duration of action is at least 24 h. Significant differences were found in the flux values of 5- FU; EDOTA and DOP enhanced the permeability of the drug about 6-fold and 11- fold respectively. Increased partition coefficient and diffusion coefficient values were obtained by these enhancers. The results suggested that the amount of EDOTA and DOP in the skin, especially in the stratum corneum, may be related to their penetration-enhancing effect.
View MoreJinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Contact:+86-21-38228826
Address:Room 505 Building 2, No 3377 Kangxin Highway, Shanghai, Republic China
LINYI FUDE FINE CHEMICAL CO.,LTD
Contact:86-539-2361184
Address:YISHUI, LINYI,SAHNDONG,CHINA
Contact:+86-27-85733560
Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Doi:10.1039/b513397a
(2005)Doi:10.1039/C8CC04285C
(2018)Doi:10.1016/j.bmcl.2004.05.070
(2004)Doi:10.1016/S0040-4039(99)00261-0
(1999)Doi:10.1021/ol036339i
(2004)Doi:10.1021/jo00414a009
(1978)